Val-Cit-PAB-MMAE is a cleavable linker-payload conjugate designed for constructing c-Met (MET)-targeting antibody-drug conjugates (ADCs) or bispecific molecules. It enables targeted delivery of the potent cytotoxin MMAE, facilitating research into targeted cancer therapies in both in vitro and in vivo experimental models.